help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bereket, A.
Right arrow Articles by Lang, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bereket, A.
Right arrow Articles by Lang, C. H.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4379-4384, Copyright © 1996 by Endocrine Society


ARTICLES

Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum

A Bereket, TA Wilson, SL Blethen, J Fan, RA Frost, MC Gelato and CH Lang
Division of Pediatric Endocrinology, State University of New York School of Medicine, Stony Brook 11794, USA.

A small portion of circulating insulin-like growth factor I (IGF-I) is detected in the free or readily dissociable state, which is thought to be the metabolically active form. The amount of free/dissociable IGF-I in serum is dependent on a complex interplay between the production rate and the concentrations of IGF-I and IGF-binding proteins (IGFBPs). IGF availability is also influenced by posttranslational changes in IGFBPs that affect the affinity of IGFBPs for IGF-I. In the present study, we examined whether a short term fast (approximately 12 h) alters the serum concentration of free/dissociable IGF-I, and whether these changes are associated with alterations in IGFBP-1 and the proteolysis status of IGFBP-3. Circulating free/dissociable IGF-I concentrations, as assessed by a two-site immunoradiometric assay, did not differ between fasting and 4 h after a morning meal (1.48 +/- 0.07 vs. 1.50 +/- 0.07 microgram/L, respectively). Likewise, free/dissociable IGF-I levels measured by RIA after separation by centrifugal ultrafiltration were not different between the two groups (1.43 +/- 0.14 vs. 1.38 +/- 0.18 microgram/L, respectively). IGF-I bioactivity, as measured by thymidine incorporation by fibroblasts, did not differ in fasting and 4-h postprandial sera. There was no difference in IGFBP-3 and total acid-ethanol-extractable IGF-I concentrations in serum from fasted and fed subjects. In contrast, the concentration of IGFBP-1 in the serum was increased approximately 5- fold in the fasted state compared to fed values. IGFBP-1 existed in a highly phosphorylated form under fasting conditions. There was no change in IGFBP-3 proteolysis assessed either in vivo or in vitro between the fasting and fed states. The results indicate that a physiologically relevant short term overnight fast does not alter the circulating levels of free/dissociable IGF-I despite a marked elevation in IGFBP-1.


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
G. Venkatasubramanian, S. Chittiprol, N. Neelakantachar, M. N. Naveen, J. Thirthall, B. N. Gangadhar, and K. T. Shetty
Insulin and Insulin-Like Growth Factor-1 Abnormalities in Antipsychotic-Naive Schizophrenia
Am J Psychiatry, October 1, 2007; 164(10): 1557 - 1560.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. M. N. Bannink, J. van Doorn, P. G. H. Mulder, and A. C. S. Hokken-Koelega
Free/Dissociable Insulin-Like Growth Factor (IGF)-I, Not Total IGF-I, Correlates with Growth Response during Growth Hormone Treatment in Children Born Small for Gestational Age
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2992 - 3000.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J.-W. Chen, M. F Nielsen, A. Caumo, H. Vilstrup, J. S. Christiansen, and J. Frystyk
Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis.
Eur. J. Endocrinol., August 1, 2006; 155(2): 285 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. E. L. Katz, D. D. DeLeon, H. Zhao, and A. F. Jawad
Free and Total Insulin-Like Growth Factor (IGF)-I Levels Decline during Fasting: Relationships with Insulin and IGF-Binding Protein-1
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2978 - 2983.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. H. Lang, X. Liu, G. J. Nystrom, and R. A. Frost
Acute response of IGF-I and IGF binding proteins induced by thermal injury
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1087 - E1096.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. J. H. M. T. van Dessel, P. D. K. Lee, G. Faessen, B. C. J. M. Fauser, and L. C. Giudice
Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3030 - 3035.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Camacho-Hübner, K. A. Woods, F. Miraki-Moud, P. C. Hindmarsh, A. J. Clark, Y. Hansson, A. Johnston, R. C. Baxter, and M. O. Savage
Effects of Recombinant Human Insulin-Like Growth Factor I (IGF-I) Therapy on the Growth Hormone-IGF System of a Patient with a Partial IGF-I Gene Deletion
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1611 - 1616.
[Abstract] [Full Text]


Home page
J. Physiol.Home page
D. W Johnson, H. J Saunders, M. J Field, and C. A Pollock
Role of insulin-like growth factor binding proteins in human post-nephrectomy proximal tubule cells
J. Physiol., April 15, 1998; 508(2): 587 - 595.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. A. Frost, C. H. Lang, and M. C. Gelato
Transient Exposure of Human Myoblasts to Tumor Necrosis Factor-{alpha} Inhibits Serum and Insulin-Like Growth Factor-I Stimulated Protein Synthesis
Endocrinology, October 1, 1997; 138(10): 4153 - 4159.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Frystyk, T. Grofte, C. Skjarbak, and H. Orskov
The Effect of Oral Glucose on Serum Free Insulin-Like Growth Factor-I and -II in Healthy Adults
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3124 - 3127.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. L. G. Nyomba, L. Berard, and L. J. Murphy
Free Insulin-Like Growth Factor I (IGF-I) in Healthy Subjects: Relationship with IGF-Binding Proteins and Insulin Sensitivity
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2177 - 2181.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. D. K. Lee, S. K. Durham, V. Martinez, O. Vasconez, D. R. Powell, and J. Guevara-Aguirre
Kinetics of Insulin-Like Growth Factor (IGF) and IGF-Binding Protein Responses to a Single Dose of Growth Hormone
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2266 - 2274.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society